Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 10,200

Document Document Title
WO/2009/036590A1
The present invention relates to novel compounds from Antrodia cinnamomea and their use.  
WO/2009/036574A1
A method of using an estrogen receptor agonist and antagonist to reduce a toxic effect of a cytostatic drug on bone marrow derived cells in a biological system. The methods comprise contacting the cells with a therapeutically effective a...  
WO/2009/027056A2
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/028643A1
Disclosed are: a highly pure, inexpensive and safe composition having a high carotenoid content; a method for the industrial production of the composition; a functional food, a pharmaceutical composition or a cosmetic comprising the comp...  
WO/2009/027056A3
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/027056A4
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/025315A1
Disclosed is a composition for increasing the amount of tetrahydrocurcumin, which is believed to be useful for the maintenance of good health or the amelioration of a disease condition, in a living body efficiently through oral intake. S...  
WO/2009/024957A1
A method of treating or preventing organophosphate exposure associated damage in a subject in need thereof is provided. The method comprising providing the subject with a therapeutically effective amount of the acetylcholinesterase splic...  
WO/2009/025326A1
Disclosed is a method for producing a hydroxytyrosol-containing aqueous olive extract, which comprises a clearing step of contacting an aqueous opaque component with diatomaceous earth, wherein the aqueous opaque component is selected fr...  
WO/2009/023742A9
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/023742A3
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/023742A2
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/020192A1
It is intended to provide a composition for oral intake which can effectively prevent skin damage induced by the exposure to ultraviolet light when orally taken. This problem can be solved by a composition for oral intake for preventing ...  
WO/2009/019260A3
The present invention provides compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury. In particular the invention provides compounds which function to suppress Toll-like Receptor 2 biological function or ...  
WO/2009/014702A2
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...  
WO/2009/013596A3
The present invention relates to nutritional products containing hydroxytyrosol, particularly food products (i.e: fortified edible oils and fortified edible oil-containing products) and dietary supplements (i.e.: soft gel capsules contai...  
WO/2009/014702A3
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...  
WO/2009/006773A1
Disclosed is an optically active N- (α-mercaptopropionyl) glycine, that is R-N- (α-mercaptopropionyl) glycine or S-N- (α-mercaptopropionyl) glycine, its preparing method, a pharmaceutical prepn. containing the same compound or its med...  
WO/2009/004842A1
It is intended to develop a technique whereby a vaccine for swine edema disease is produced at a low cost and a high efficiency. More specifically, swine edema disease toxic protein (Stx2e protein) gene is expressed in a plant cell at a ...  
WO/2009/001322A2
The inventors have studied the kinetic and hierarchy of activation of apoptogenic caspases during myocardial ischemia and have found that caspase 2 plays a major role during the cardiac pathology by a very fast activation after an ischem...  
WO/2009/001322A3
The inventors have studied the kinetic and hierarchy of activation of apoptogenic caspases during myocardial ischemia and have found that caspase 2 plays a major role during the cardiac pathology by a very fast activation after an ischem...  
WO/2008/155487A2
The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter...  
WO/2008/157802A1
This invention provides compounds of Formula (I), which are inhibitors of Chk2 and are useful as a radiation protection agents in anticancer radiotherapy. A method of modulating Chk2 in vitro includes treating a substrate with Chk2 in th...  
WO/2008/157393A1
The present invention provides methods of stimulating angiogenesis and the growth or migration of cells associated with angiogenesis, by contacting animals, tissues, or cells with sulfide, alone or in combination with nitric oxide. These...  
WO/2008/153385A1
The invention relates to derivatives of urocanic acid that have improved efficacy and/or tissue penetration properties. The invention further provides use of these derivatives in a medicament for modulating an immune-related disease in a...  
WO/2008/152173A1
This invention concerns phenolic extracts containing procyanidins, propelargonidins and prodelfinidins obtained from peel of the almond [Prunus dulcís (Mili.) D.A. Webb, Prunus amygdalus (L.) Batsch., Amygdalus dulcís (Mili.), Amygdalu...  
WO/2008/149688A1
[PROBLEMS] To provide: a composition having an excellent antioxidative activity; a food or beverage utilizing the composition; and a method for producing the composition. [MEANS FOR SOLVING PROBLEMS] Disclosed are: a composition comprisi...  
WO/2008/149689A1
[PROBLEMS] To provide: a composition having an excellent antioxidative activity; a food or beverage utilizing the composition; and a method for producing the composition. [MEANS FOR SOLVING PROBLEMS] Disclosed are: a composition comprisi...  
WO/2008/145865A2
The present invention relates to mutated hyperthermophilic phosphotriesterases (PTEs) which have lactonase activity, and to the uses thereof as biopurifiers in the context of the decontamination of surfaces of materials, of the skin or o...  
WO/2008/147480A3
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/144912A1
New mutant forms of dihydrofolate reductase (DHFR) which are resistant to antifolate agents such as methotrexate are described. These mutants may be used, for example, as selectable markers and in gene therapy applications.  
WO/2008/147480A4
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/144916A1
This invention relates to a method of reducing the side effects of isoniazid. Specifically, the invention relates to administration of pyridoxal 5'-phosphate to reduce or mitigate the side effects of isoniazid. Also provided is the use o...  
WO/2008/147480A2
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/147480A8
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/147562A2
Dietary formulations in the form of an oil emulsion providing total enteral or parenteral nutrition, or in the form of food oil suitable for oral administration is provided. The formulations include about 2-60% by calories of a C20 or lo...  
WO/2008/143182A1
Disclosed is a composition comprising a licorice-derived polyphenol and an active ingredient other than the licorice-derived polyphenol (an antioxidant component, a polyphenol other than the licorice-derived polyphenol, or a component in...  
WO/2008/138358A1
Electrolyzed water with pH = 9.5 +/- 1.5 & ORP = -250 to -400 mv used for drinking for maintaining human health since it has antioxidant effects thus prevents a lot of diseases. Also it can be used for diet as it neutralizes excess acidi...  
WO/2008/135984A1
The present invention relates to S-allylmercapto-N-acetylcysteine (ASSNAC) and its pharmaceutically acceptable salts and solvates, which are useful for up-regulation of cellular glutathione levels and expression of phase II detoxifying e...  
WO/2008/134630A1
Methods are disclosed of treating conditions associated with iron and calcium overload comprising administering an effective amount of dexrazoxane or a non- dexrazoxane compound of formula (IA), (IB), or (IC) or a pharmaceutically accept...  
WO/2008/129980A1
Disclosed is a particulate composition which contains reduced coenzyme Q10 and which has both high stability in oxygen and high bioabsorbability in the field of a food, a food with a nutrient function, a food for specified health uses, a...  
WO/2008/130395A3
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, the actinide decorporation agent comprising a hexacoordinate desferrithiocin ana...  
WO/2008/130395A2
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, the actinide decorporation agent comprising a hexacoordinate desferrithiocin ana...  
WO/2008/129720A1
It is intended to provide a moisturizing agent, an antiaging agent, a whitening agent, an antioxidant, a slimming agent, a treatment agent and an alginase activity promoter which contain an extract of a plant belonging to the genus Cynan...  
WO/2008/126752A1
A skin-lightening agent containing a novel skin-lightening ingredient as an active ingredient. The active ingredient comprises equol and/or an equol glycoside formed by bonding one or more glycosyl groups to one or more of the hydroxy gr...  
WO/2008/125724A1
The present invention relates to monitoring ofoxidative metabolism and is, particularly, directed to a method for the estimation of lipid peroxide load or the consequent inflamma- torystate of a subject by measuring the concentration of ...  
WO/2008/123093A1
Disclosed is an agent for prevention or treatment of iron overload, which contains 22β-methoxyolean-12-ene-3β,24(4β)-diol or a pharmacologically acceptable salt thereof.  
WO/2008/119556A3
The present invention relates to a method for producing an extract which is capable of inducing an antioxidant stress response comprising the step of treating an extract from organic material with UV light, said extract being derived fro...  
WO/2008/119852A1
Extract of Couroupita guianenis leaves, method for obtaining same and cosmetic use thereof as an antioxidant/antiradical/UV (ultraviolet) filter. Extracts obtained from dry, ground and sieved leaves, extraction with water and/or alcohols...  
WO/2008/120708A1
It is intended to provide a means for enhancing the engraftment rate or proliferation rate in a transplanted tissue in vivo by establishing a tissue transplantation method wherein a single donor is sufficient for a single recipient with ...  

Matches 601 - 650 out of 10,200